iSERA Lifesciences Allots 1.62 Crore Equity Shares via Share Swap
iSERA Lifesciences Ltd 路 Others (Uncategorized) 路 01 Oct 2026, 5:34 pm
iSERA Lifesciences Allots 1.62 Crore Equity Shares via Share Swap The Board of Directors of iSERA Lifesciences Limited approved the preferential allotment of 1,61,82,800 fully paid-up equity shares (face value Rs. 10 each) at an issue price of Rs. 48.20 per share (including Rs. 38.20 premium) on 1st Oct'26. The issuance is for non-cash consideration via a 1:1 share swap to acquire shares of iSERA Biological Limited from 196 promoter and non-promoter allottees. Consequently, the company's paid-up equity share capital expands from 84,08,972 shares to 2,45,91,772 shares.
Original exchange filing (PDF)
More announcements from iSERA Lifesciences Ltd
- Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Administrative Warning Letter received .... 路 15 Nov 2026
- Dissemination of Warning Letter of SEBI 路 12 Nov 2026
- We hereby submit the revised un-Audited Financial result for Half year ended September 2026 under regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 路 05 Nov 2026
- We hereby submit that pursuant to Regulation 15(2) of SEBI (LODR) Regulations, 2015, the compliance with the corporate governance provisions as specified in Regulations 17, 18, 19, 20, .... 路 04 Nov 2026
- We hereby submit the Un-Audited Financial Result for the quarter and half yearly ended September 2026 路 04 Nov 2026
- Outcome of the Board Meeting held today on 4th November 2026 under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 路 04 Nov 2026
- Isera Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2026 ,inter alia, to consider and approve the Un-Audited Financial .... 路 04 Nov 2026
- Disclosure under Regulation 7(2) read with Regulation 6(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015 - Continual Disclosure consequent to Preferential Allotment of .... 路 09 Oct 2026
